This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Michele Pistollato

Principal

London
+44 20-7959-1415

mpistollato@crai.com

01

Adapting ICER to transformative medicines

Our client is a global pharma company and is interested to understand the implications of the 2019/2020 updates to the ICER Value Assessment Framework...
View engagement
02

EU Orphan Medicines Regulation Review

The purpose of the project was to delver an external report that evaluates the broader economic and societal impact of the Orphan Medicine Product (OMP)...
View engagement

Life Sciences
Speaking Engagement

November 30 - December 3, 2021

Virtual

ISPOR Europe 2021

Michele Pistollato and Elaine Damato are presenting a poster at on “How should public health recommendations address Lp(a), a causative risk factor for...

Life Sciences
Speaking Engagement

May 17-20, 2021

Virtual

ISPOR 2021

Tim Wilsdon is a panelist during the session titled “Access to Oncology Combinations – the ‘Combination Challenge.'” Michele Pistollato is presenting two...

Michele Pistollato

London +44 20-7959-1415 mpistollato@crai.com